Alerts

The TGA has performed and reported on a large number of tests on the chemical properties, physical properties and the biological safety of the gels and shells of PIP breast implants.

GlaxoSmithKline (GSK) and Alphapharm, in consultation with the TGA, are undertaking a voluntary recall of several batches of Ventolin and Asmol inhalers due to a fault in the delivery mechanism of a small number of inhalers within each batch. This can lead to less than the full dose being delivered for each puff.

Poly Implant Prothèse (PIP) update

Health professionals and consumers are advised that Advanced Surgical Design & Manufacture (ASDM), in conjunction with the TGA, is investigating elevated failure rates of the patella (knee cap) component of the Active Knee System—an implant used in knee replacement procedures.

Poly Implant Prothèse (PIP) update

Poly Implant Prothèse (PIP) update

The TGA advises health professionals and patients that Global Orthopaedic Technology has cancelled the Apex K2 Femoral Stem from the Australian Register of Therapeutic Goods (ARTG).

The TGA advises health professionals and patients that Zimmer has cancelled the implant from the Australian Register of Therapeutic Goods (ARTG).

We are recalling all batches of Muscletech Hydroxystim capsules due to the presence of the banned substance DMAA. Consult your doctor if you have concerns.

Six batches of Infanrix hexa vaccine are being recalled due to potential contamination with Bacillus cereus. Consult your doctor if you have concerns.

Some batches of the Typhim Vi Vaccine are being recalled due to lower antigen content. Consult your doctor if you have concerns.

We are recalling Serenace (haloperidol) 0.5mg tablets from batch BJ431 due to mould contamination. Consult your doctor if you have concerns.

Poly Implant Prothèse (PIP) update